For research purposes only. Not for human consumption.
Back to Catalog
Tesamorelin + Ipamorelin 10 mg + 5 mg

Tesamorelin + Ipamorelin

10 mg + 5 mg

$65

Research Use Only

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Must be 21 or older to purchase.

Measurement Key

mg = milligram; mcg = microgram; 1 mg = 1,000 mcg. mL = liquid volume. A U-100 syringe has 100 marked volume units per mL: one marking is 0.01 mL and ten are 0.10 mL. These markings are NOT peptide International Units (IU). A physical syringe may not have one-unit or half-unit graduations; do not imply it can measure a value more precisely than its scale permits. Concentration = total amount / measured FINAL volume. Quantity in a sample = concentration × sample volume. Required volume = a protocol-specified quantity / verified concentration. The calculator checks arithmetic only; it cannot select a clinical dose or establish suitability, stability or sterility.

Research Information

Contents

15 mg total blend; 2:1 tesamorelin-to-ipamorelin ratio.

Clinical evidence and research limitations

No clinical trial proving the benefits of this exact blend was verified. Tesamorelin-alone trial findings cannot establish added benefit, safety or stability of ipamorelin in this mixture.

Dosing evidence

Human dosing: no validated regimen for this exact research product was established in the reviewed sources. Insufficient data to verify a starting dose, escalation schedule, frequency, cycle, maximum dose or injection route. No human-use directions are supplied.

Reconstitution

This is a powder-vial calculation reference, not a validated preparation recipe. Confirm the exact formulation, compatible diluent, final volume, container capacity, mixing method and storage with the manufacturer. Do not interpret the example as a direction to add that volume of BAC water.

Measurement example

MATHEMATICAL EXAMPLE ONLY, at 3.0 mL FINAL volume: tesamorelin = 3.33333 mg/mL; ipamorelin = 1.66667 mg/mL; total = 5 mg/mL. One U-100 marking ≈ 33.3333 mcg tesamorelin + 16.6667 mcg ipamorelin. Ten markings ≈ 333.333 mcg + 166.667 mcg. A reference pair of 500 mcg + 250 mcg occupies 0.15 mL (15 markings). These are conversions, not recommended doses. The source page is a different 5 mg + 5 mg blend and its component table is internally inconsistent; do not copy its unit column.

Possible side effects

The exact blend's adverse-effect profile is unverified. Tesamorelin-label concerns may be relevant but are not a validated blend profile. FDA identifies ipamorelin safety uncertainties.

Storage

Follow the original lot-specific supplier instructions before and after preparation. Temperature, light protection, freezing limits and discard date: insufficient data to verify. The calculation volume does not establish stability or a use-by period.

Sources

Source access date: October 25, 2026. Secondary calculation references (peptidedosages.com) are community resources, not clinical trials. Their example volumes do not validate these products.

Responding to possible adverse effects: The side-effect summaries are incomplete and do not establish the safety of the inventory. Unknown risks must not be described as "no side effects." For anyone experiencing breathing difficulty, facial/throat swelling, fainting, severe persistent abdominal pain or other severe symptoms after an exposure, seek urgent medical care and provide the product/lot details.

Preparation and Handling Information

The original product instructions must establish substance identity, component ratio, excipients, compatible diluent, required amount, final volume, mixing method, container suitability, storage and discard interval. A 3 mL container does not automatically require 3 mL water. Any powder displacement and final-volume instructions must be accounted for. Do not transfer the storage rules for a branded finished medicine to a different research powder. No universal refrigerated shelf life, freezer shelf life or "28 days after mixing" period is established for this catalog. Lack of visible particles is not proof of sterility. Do not use a damaged, leaking, unexpectedly altered or undocumented preparation.